{"number":"US12697314B2","kindCode":"B2","documentType":"grant","title":{"original":"Pharmaceutical composition for treating autosomal dominant polycystic kidney disease","english":"Pharmaceutical composition for treating autosomal dominant polycystic kidney disease"},"abstract":{"original":"A new dosage regimen of a pharmaceutical composition comprising tamibarotene as the active ingredient for treating autosomal dominant polycystic kidney disease. A pharmaceutical composition comprising tamibarotene for the treatment or prevention of autosomal dominant polycystic kidney disease (ADPKD), wherein the composition is administered orally to a patient with ADPKD in an amount of 1.4-5.5 mg/day, particularly 4.0 mg/day of tamibarotene.","english":"A new dosage regimen of a pharmaceutical composition comprising tamibarotene as the active ingredient for treating autosomal dominant polycystic kidney disease. A pharmaceutical composition comprising tamibarotene for the treatment or prevention of autosomal dominant polycystic kidney disease (ADPKD), wherein the composition is administered orally to a patient with ADPKD in an amount of 1.4-5.5 mg/day, particularly 4.0 mg/day of tamibarotene."},"applicants":["NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY","KYOTO UNIVERSITY"],"inventors":["Kenji OSAFUNE","Shinichi MAE","Saori NISHIO","Fumihiko HATTANDA","Tsuyoshi NAKANO","Ryuichiro HIRAYAMA","Tomoko SUZUKI","Ayuto HAYASHI"],"filingDate":"2025-06-18","publicationDate":"2026-08-04","grantDate":"2026-08-04","verifiedWithOffice":true,"pdfUrl":"https://downloadpatent.com/pdf/US12697314B2.pdf","pages":{"en":"https://downloadpatent.com/patent/US12697314B2","zh-Hant":"https://downloadpatent.com/zh-Hant/patent/US12697314B2","ja":"https://downloadpatent.com/ja/patent/US12697314B2"}}